Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03418532
Title MP0250 DARPin Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Molecular Partners AG
Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.